Vanguard VXUS vs. iShares IXUS: Which ETF Wins This International Showdown?

Vanguard VXUS vs iShares IXUS offer nearly identical international exposure and risk (beta ~0.76 vs 0.77, max drawdown ~-29.4% vs -30%), with only modest differences in costs and income. VXUS is marginally cheaper at a 0.05% expense ratio vs 0.07% for IXUS, while IXUS has a slightly higher trailing dividend yield (2.9% vs 2.6%). VXUS leads in liquidity and scale with $652.3B AUM vs $58.9B, which may favor investors looking for tighter trading execution.

Analysis

This is not a fundamental call on international equities so much as a wrapper-selection trade. The only real edge here is implementation: VXUS should continue to win incremental model-portfolio and retail flows because liquidity and scale matter more than a 2 bp fee gap when allocators need tight spreads and low market-impact. IXUS is not “bad,” but on large tickets its thinner AUM creates a small but persistent execution disadvantage that can show up in advisor platforms and rebalance windows.

The second-order point is that both funds are just beta containers for the same macro regime: dollar trend, global manufacturing PMIs, and semiconductor cycle drive most of the return dispersion. That means the true winners are TSM and SSNLF if the AI/hardware capex cycle stays intact; the true losers would be the wrapper itself if ex-US underperforms the U.S. for another 6-12 months, because fee sensitivity gets amplified when returns are flat. On a 1-3 month horizon, there is no obvious catalyst for one ETF to separate meaningfully unless there is a sharp rotation in model portfolios toward the cheapest/liquid vehicle.

Contrarian view: the market is overfitting to fee differences and underestimating tracking/implementation. Over 6-18 months, the marginal 2 bps matters less than dividend timing, FX, and underlying country mix. If the dollar weakens or Europe/Japan cyclicals re-rate, both funds benefit similarly; if not, neither wrapper changes the outcome. The clean thesis is that there may be no trade here unless you are reallocating a core sleeve and care about tradability, in which case VXUS is the cleaner default.

Key Decisions for Investors

• Prefer VXUS over IXUS for new passive international allocations over the next 1-3 months; the higher liquidity and lower fee are the only durable advantages, with low implementation risk
• Do not switch existing IXUS positions solely for the 2 bp fee spread unless the ticket size is large and holding period exceeds 5+ years; expected alpha is likely below transaction-cost noise
• If the goal is to express ex-US upside, use country/sector-level exposure rather than the ETF wrapper: TSM or SSNLF for semis, since those names will dominate performance if global capex re-accelerates
• Set a watch item on USD weakness and global PMI inflection; if both turn supportive, both funds should re-rate together, making any VXUS/IXUS relative trade uninteresting
• If forced into a pair, keep it small: long VXUS / short IXUS only as a liquidity/flow arb, not a directional macro trade; thesis fails if IXUS closes the AUM gap or if spreads normalize materially